Absorica ld and Weight decreased - a phase IV clinical study of FDA data


Weight decreased is reported only by a few people who take Absorica Ld.

The phase IV clinical study analyzes which people take Absorica ld and have Weight decreased. It is created by eHealthMe based on reports of 73 people who have side effects while taking Absorica ld from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

73 people reported to have side effects when taking Absorica ld.
Among them, 2 people (2.74%) have Weight decreased.

What is Absorica ld?

Absorica ld has active ingredients of isotretinoin. eHealthMe is studying from 73 Absorica ld users for its effectiveness, alternative drugs and more.

What is Weight decreased?

Weight decreased is found to be associated with 4,443 drugs and 4,553 conditions by eHealthMe.

Number of Absorica ld and Weight decreased reports submitted per year:

Could Absorica ld cause Weight decreased?

Gender of people who have Weight decreased when taking Absorica ld*:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Absorica ld and have Weight decreased?

Check whether Weight decreased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Weight decreased and when was it recovered:

Expand to all the drugs that have ingredients of isotretinoin:

Alternative drugs to, pros and cons of Absorica ld:

Weight decreased treatments and more:

COVID vaccines that are related to Weight decreased:

Common drugs associated with Weight decreased:

All the drugs that are associated with Weight decreased:

Common conditions associated with Weight decreased:

All the conditions that are associated with Weight decreased:

How the study uses the data?

The study uses data from the FDA. It is based on isotretinoin (the active ingredients of Absorica ld) and Absorica ld (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: